Skip to content

Optical Transcutaneous Sensors of Capnia and Oxygenation

Validation of Optical Transcutaneous Sensors to Measure Capnia and Tissue Oxygenation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03992651
Acronym
CTCO
Enrollment
20
Registered
2019-06-20
Start date
2019-06-12
Completion date
2019-10-11
Last updated
2025-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Gas Monitoring, Transcutaneous

Brief summary

This study aims at validating new optical transcutaneous sensors to evaluate tissue capnia (CO2 partial pressure) and oxygenation (blood oxygen saturation) by comparing them to standard laboratory measurements (end tidal CO2 measurements and oxygen saturation by near-infrared spectroscopy).

Interventions

DEVICEMeasurements of capnia and tissue oxygenation by optical transcutaneous sensors

Capnia and tissue oxygenation will be measured by optical transcutaneous sensors

Sponsors

University Hospital, Grenoble
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

One single group will have simultaneous measurements of capnia and tissue oxygenation by the new sensors and by the standard laboratory sensors

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Males or females between 18 and 50 year old * Individual having health insurance * Individual able to provided informed consent * Subjects with no known pathology and not taking any medical treatment a priori capable of interfering with controlled hypoxia at levels required in the protocol

Exclusion criteria

* Body mass index \>27 kg/m² * History of acute mountain sickness * Chronic diseases know to be associated with high methemoglobinemia * Known allergy to one of the materials used in the devices (lycra, polyamide...), or to the adhesive plaster. * Active smoker (\>3 cigarets/day) * Alcohol consumption (\>10g/day) * Individual with high skin sensitivity due to skin diseases * Mental disorders * Persons who refuse to sign the information sheet and participation agreement * Persons under guardianship or not subject to a social security system * Pregnant woman, parturient, breastfeeding mother * Person deprived of liberty by judicial or administrative decision * A person who is subject to a legal protection measure that cannot be included in clinical trials.

Design outcomes

Primary

MeasureTime frameDescription
Comparison of capnia valuesContinuous measurement during the only experimental session (1 hour)Comparison of capnia values measured by the new sensors and the standard laboratory sensors

Secondary

MeasureTime frameDescription
Comparison of tissue oxygenation valuesContinuous measurement during the only experimental session (1 hour)Comparison of tissue oxygenation values measured by the new sensors and the standard laboratory sensors

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026